Bevacizumab (R435)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Bevacizumab (R435), covering 2012-04-26 to 2012-04-26. Get the full timeline:
Most recent: Clinical Trial Update: Phase Ⅱ Clinical Study of R435 (Bevacizumab) in Combination With Paclitaxel in Patients With Inoperable Metastatic Breast Cancer [Phase 2]